MBX - CIK 0001776111
MBX Biosciences, Inc. (MBX) reported net income of -$87.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$87.00M | -40.5% |
| FY 2024 | -$61.92M | -90.2% |
| FY 2023 | -$32.56M | - |
MBX Biosciences, Inc. (MBX) reported net income of -$87.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.